Global Aflibercept Market, By Type (Prefilled Syring Package, and Vial Package), Application (Wet Macular Degeneration, Metastatic Colorectal Cancer, Diabetic Macular Oedema, Diabetic Retinopathy, Others), Route of Administration (Intravenous and Intravitreal Injection), End-Users (Clinics, Hospitals, Diagnostic centers, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Aflibercept Market
Global aflibercept market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account for growing at a CAGR of 5.40% in the above mentioned forecast period.
Aflibercept is a vascular endothelial growth factor-A (VEGF-A) antagonist which is used for the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic retinopathy, and various types of muscular edema. It acts as a soluble decoy receptor which results in the binding of VEGF-A, VEGF-B, and placental growth factor (PIGF) and shows higher affinity. It is a medication which is traded under the brand names Eylea and Zaltrap.
Rise in the prevalence of wet maculat degeneration, metastatic colorectal cancer, visual impairment because of diabetic macular edema, and diabetic retinopathy will increase the market growth. Advancement of therapies for the treatment and increasing geriatric population are the expected factors that will increase the growth of aflibercept market. Growing government funds and support will also expand the aflibercept market.
Rise in number of R&D activities, ongoing clinical trials, and rise in approvals for a new treatment are expected to provide beneficial opportunities for the global aflibercept market in the forecast period of 2021-2028.
High cost of treatment, presence of other alternative medications, and trade barriers are the factors that will restrict the market growth and will further challenge the global aflibercept market in the forecast period mentioned above.
This aflibercept market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global aflibercept market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Aflibercept Market Scope and Market Size
The aflibercept market is segmented on the basis of type, application, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the aflibercept market is segmented into prefilled syringe package and vial package.
- On the basis of application, the aflibercept market is segmented into wet macular degeneration, metastatic colorectal cancer, diabetic macular edema, diabetic retinopathy, and other’s.
- On the basis of route of administration, the aflibercept market is segmented into intravenous and intravitreal injection.
- On the basis of end-users, the aflibercept market is segmented into clinics, hospitals, diagnostic centres, and others.
- The aflibercept market is also segmented on the basis of distribution channels into hospital pharmacy, retail pharmacy, and online pharmacy.
Global Aflibercept Market Country Level Analysis
Global aflibercept market is analyzed, and market size information is provided by the country, type, application, route of administration, end-users and distribution channel as referenced above.
The countries covered in the global aflibercept market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the aflibercept market due to the existence of major key players, high prevalence rate, increasing social awareness, well-developed healthcare sector and increase in the government support for research & development in this region. Global aflibercept market in the Europe and Asia-Pacific is expected to grow during the forecast period, because of growing focus of pharmaceutical companies on advancement of therapies for treatment, growing government support and rising healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global aflibercept market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Aflibercept Market Share Analysis
Global aflibercept market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global aflibercept market.
The major players covered in the global aflibercept market report are Bayer AG, Sanofi, Santen Pharmaceutical Co.,Ltd., Regeneron Pharmaceuticals Inc., and F. Hoffmann-La Roche Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.